UBS O'Connor’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Sell |
35,668
-183
| -0.5% | -$16K | 0.16% | 97 |
|
|
2025
Q1 | $2.45M | Buy |
35,851
+8,947
| +33% | +$611K | 0.07% | 103 |
|
|
2024
Q4 | $2.09M | Buy |
26,904
+2,547
| +10% | +$198K | 0.06% | 149 |
|
|
2024
Q3 | $1.63M | Buy |
24,357
+9,357
| +62% | +$627K | 0.04% | 199 |
|
|
2024
Q2 | $1.7M | Buy |
+15,000
| New | +$1.7M | 0.05% | 219 |
|
|
2024
Q1 | – | Sell |
-6,172
| Closed | -$766K | – | 462 |
|
|
2023
Q4 | $766K | Sell |
6,172
-18,828
| -75% | -$2.34M | 0.02% | 294 |
|
|
2023
Q3 | $2.33M | Buy |
+25,000
| New | +$2.33M | 0.04% | 218 |
|